A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral Sinemet® (Levodopa/Carbidopa)
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral Sinemet®
(Levodopa/Carbidopa) Doses Administered Using a Divided Dose Approach
Phase:
Phase 1
Details
Lead Sponsor:
NeuroDerm Ltd.
Collaborator:
Quotient Clinical
Treatments:
Carbidopa Carbidopa, levodopa drug combination Levodopa